Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach - PubMed (original) (raw)
Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach
Alba Franquesa et al. Psychiatry Res. 2018 Jun.
Abstract
Ayahuasca is a psychedelic decoction originating from Amazonia. The ayahuasca-induced introspective experience has been shown to have potential benefits in the treatment of several pathologies, to protect mental health and to improve neuropsychological functions and creativity, and boost mindfulness. The underlying psychological processes related to the use of ayahuasca in a psychotherapeutic context are not yet well described in the scientific literature, but there is some evidence to suggest that psychological variables described in psychotherapies could be useful in explaining the therapeutic effects of the brew. In this study we explore the link between ayahuasca use and Decentering, Values and Self, comparing subjects without experience of ayahuasca (n = 41) with subjects with experience (n = 81). Results confirm that ayahuasca users scored higher than non-users in Decentering and Positive self, but not in Valued living, Life fulfillment, Self in social relations, Self in close relations and General self. Scores in Decentering were higher in the more experienced subjects (more than 15 occasions) than in those with less experience (less than 15 occasions). Our results show that psychological process variables may explain the outcomes in ayahuasca psychotherapy. The introduction of these variables is warranted in future ayahuasca therapeutic studies.
Keywords: Ayahuasca; Contextual therapy; Decentering; Psychedelics; Psychotherapy; Self; Values.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
- Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers.
Murphy-Beiner A, Soar K. Murphy-Beiner A, et al. Psychopharmacology (Berl). 2020 Apr;237(4):1161-1169. doi: 10.1007/s00213-019-05445-3. Epub 2020 Jan 11. Psychopharmacology (Berl). 2020. PMID: 31927605 - Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.
Soler J, Elices M, Franquesa A, Barker S, Friedlander P, Feilding A, Pascual JC, Riba J. Soler J, et al. Psychopharmacology (Berl). 2016 Mar;233(5):823-9. doi: 10.1007/s00213-015-4162-0. Epub 2015 Nov 27. Psychopharmacology (Berl). 2016. PMID: 26612618 - Ayahuasca may help to improve self-compassion and self-criticism capacities.
Domínguez-Clavé E, Soler J, Elices M, Franquesa A, Álvarez E, Pascual JC. Domínguez-Clavé E, et al. Hum Psychopharmacol. 2022 Jan;37(1):e2807. doi: 10.1002/hup.2807. Epub 2021 Aug 19. Hum Psychopharmacol. 2022. PMID: 34411343 - Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J, Hallak J, Dursun SM, Baker G. Hamill J, et al. Curr Neuropharmacol. 2019;17(2):108-128. doi: 10.2174/1570159X16666180125095902. Curr Neuropharmacol. 2019. PMID: 29366418 Free PMC article. Review. - Ayahuasca and the traveller: A scoping review of risks and possible benefits.
Houle SKD, Evans D, Carter CA, Schlagenhauf P. Houle SKD, et al. Travel Med Infect Dis. 2021 Nov-Dec;44:102206. doi: 10.1016/j.tmaid.2021.102206. Epub 2021 Nov 14. Travel Med Infect Dis. 2021. PMID: 34785376 Review.
Cited by
- The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.
Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. Dos Santos RG, et al. Risk Manag Healthc Policy. 2021 Mar 5;14:901-910. doi: 10.2147/RMHP.S300656. eCollection 2021. Risk Manag Healthc Policy. 2021. PMID: 33707976 Free PMC article. Review. - Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
Agin-Liebes G, Nielson EM, Zingman M, Kim K, Haas A, Owens LT, Rogers U, Bogenschutz M. Agin-Liebes G, et al. Psychol Addict Behav. 2024 Feb;38(1):101-113. doi: 10.1037/adb0000935. Epub 2023 Jun 5. Psychol Addict Behav. 2024. PMID: 37276086 Clinical Trial. - The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. Zaretsky TG, et al. Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147. Curr Neuropharmacol. 2024. PMID: 38284341 Free PMC article. Review. - Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits.
Domínguez-Clavé E, Soler J, Pascual JC, Elices M, Franquesa A, Valle M, Alvarez E, Riba J. Domínguez-Clavé E, et al. Psychopharmacology (Berl). 2019 Feb;236(2):573-580. doi: 10.1007/s00213-018-5085-3. Epub 2018 Nov 7. Psychopharmacology (Berl). 2019. PMID: 30406413 - Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center.
Rush B, Marcus O, García S, Loizaga-Velder A, Loewinger G, Spitalier A, Mendive F. Rush B, et al. Front Pharmacol. 2021 May 19;12:659644. doi: 10.3389/fphar.2021.659644. eCollection 2021. Front Pharmacol. 2021. PMID: 34093190 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical